摘要
在中药专利创新激励机制中,充分公开的认定标准应该在保持其规范性的前提下体现中药传承创新规律与技术特点,以促进创新激励功能之发挥。中药专利数量不足、质量不高的问题暴露了现行认定标准存在忽略特定创新主体专利需求、无法有效公开中药专利信息的制度缺陷。充分公开认定标准本应具备激励多元主体协同创新并促进专利权利信息扩散的价值目标进一步验证了上述不足。为解决创新激励失灵之现实问题,中药专利充分公开的认定标准应从法律适用及规则制定的双重维度进行完善:一方面通过“所属领域技术人员”的解释与适用增加充分公开认定标准的灵活性与技术适应性,另一方面借助专利审查实践细化中药专利充分公开中“能够实现”与“得到支持”的认定标准。
In patent innovation incentive mechanism of Traditional Chinese Medicine(TCM),patent disclosure requirement should adapt to the inherit innovation model and technical characteristics of TCM in order to promote the innovation.The practical problems of insufficient quantity and low quality of TCM patents expose the defects of current system,which neglect the patent application needs of specific innovators and fail to disclose patent information of TCM effectively.The above shortcomings are further verified by the value objective of disclosure requirement.which should coordinate innovation of multi-innovators and promoting the diffusion of patent claim information.To deal with the innovation incentive failure,the standard of disclosure requirement of TCM should be improved from the perspectives of law application and rulemaking.On the one hand,through the application of"the person skilled in the art",the flexibility and technical adaptability of disclosure requirement shall be increased.On the other hand,by the means of patent examination practices,the criteria of"enablement"and"written description"shall berefined.
出处
《河南大学学报(社会科学版)》
CSSCI
北大核心
2024年第2期46-52,153,共8页
Journal of Henan University(Social Sciences)
基金
国家社会科学基金重大项目“总体国家安全观下产业知识产权风险治理现代化研究”(21&ZD203)阶段性成果
中南财经政法大学青年教师创新研究专项“基因专利信息公开制度中落实总体国家安全观的经验与路径”阶段性成果。